ArticleBMC medicine2026

Oncostatin-M ligand-based CAR-T therapy displays robust anti-tumor activity against osteosarcoma.

Daniel Feinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.